Temozolomide (Temodar, Temodal)

Epidemiology

  • Used to treat glioblastoma and metastatic melanoma

Pharmacology

  • Alkylating agent

Adverse Effects

  • Pneumonitis (see [[Pneumonia]]): occurs in 4.8% of cases
  • Cryptogenic Organizing Pneumonia (see [[Cryptogenic Organizing Pneumonia]]): one case report
    • Resolved with discontinuation of drug
  • Pharyngitis
  • Sinusitis
  • Cough
  • Upper Respiratory Tract Infection
  • Dyspnea

References

  • xxx